RAC1b overexpression correlates with poor prognosis in KRAS/BRAF WT metastatic colorectal cancer patients treated with first-line FOLFOX/XELOX chemotherapy-Reference-Cited by-同舟云学术

RAC1b overexpression correlates with poor prognosis in KRAS/BRAF WT metastatic colorectal cancer patients treated with first-line FOLFOX/XELOX chemotherapy

Published:2014-07 Issue:11 Volume:50 Page:1973-1981
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Alonso-Espinaco Virginia,Cuatrecasas Miriam,Alonso Vicente,Escudero Pilar,Marmol Maribel,Horndler Carlos,Ortego Javier,Gallego Rosa,Codony-Servat Jordi,Garcia-Albeniz Xabier,Jares Pedro,Castells Antoni,Lozano Juan José,Rosell Rafael,Maurel Joan

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference29 articles.

1. Somatic profiling of the epidermal growth factor receptor pathway in tumors from patients with advanced colorectal cancer treated with chemotherapy ± cetuximab;Smith;Clin Cancer Res,2013

2. Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status;Van Cutsem;J Clin Oncol,2011

3. Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial;Maughan;Lancet,2011

4. Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer;Douillard;N Engl J Med,2013

5. Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis;De Roock;Lancet Oncol,2010

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Roles of RAC1 and RAC1B in Colorectal Cancer and Their Potential Contribution to Cetuximab Resistance;Cancers;2024-07-06

2. Targeted splicing therapy: new strategies for colorectal cancer;Frontiers in Oncology;2023-08-17

3. Proteomic Profiling of Chemotherapy Responses in FOLFOX-Resistant Colorectal Cancer Cells;International Journal of Molecular Sciences;2023-06-08

4. Pro-Inflammatory Cytokines Trigger the Overexpression of Tumour-Related Splice Variant RAC1B in Polarized Colorectal Cells;Cancers;2022-03-09

5. The RNA-Binding Protein ESRP1 Modulates the Expression of RAC1b in Colorectal Cancer Cells;Cancers;2021-08-13